Jacobs Engineering Group Inc.

Jacobs Engineering Group Inc.

September 07, 2005 07:45 ET

Jacobs Selected for Pfizer Swedish Biotech Project

PEAPACK, N.J.--(CCNMatthews - Sep 7, 2005) -

Jacobs Engineering Group Inc. (NYSE:JEC) announced today that they have been selected to develop a concept and preliminary design for a new biotech pharmaceutical facility for Pfizer, Inc., at Pfizer's Strangnas Manufacturing Center in Sweden.

Officials did not disclose the contract value.

The new facility enables Pfizer to ensure manufacturing capacity for existing biotech-derived pharmaceutical products. Jacobs is designing the manufacturing facility in accordance with current Good Manufacturing Practices (cGMP), Pfizer quality standards, and U.S. Food and Drug Administration and the European Medicines Agency licensing requirements for bulk API (active pharmaceutical ingredient) production. Jacobs is executing the work from their office in Reading, England. Pfizer currently ranks as the world's largest manufacturer of pharmaceuticals and is committed to improving the quality of life for millions of people on a global basis.

In making the announcement, Jacobs Group Vice President Phil Stassi stated, "We are excited to become part of Pfizer's biotech initiative. This award combines the product technology strengths of Pfizer with the global biotech project delivery expertise of Jacobs as we work together in support of Pfizer's commitment to provide life enhancing pharmaceuticals."

Jacobs, with over 35,000 employees and revenues exceeding $5.0 billion, provides technical, professional, and construction services globally.

Any statements made in this release that are not based on historical fact are forward-looking statements. Any forward-looking statements made in this release represent management's best judgement as to what may occur in the future. However, Jacobs' actual outcome and results are not guaranteed and are subject to certain risks, uncertainties and assumptions ("Future Factors"), and may differ materially from what is expressed. For a description of Future Factors that could cause actual results to differ materially from such forward-looking statements, see the discussion under the section "Forward-Looking Statements" included in Item 7 -- Management's Discussion and Analysis of Financial Condition and Results of Operations contained in the Company's 2004 Annual Report on Form 10-K.

Contact Information

  • Jacobs Engineering Group Inc.
    Rod Sharp, 626-578-6992